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ABSTRACT
The integrity of transplanted mesenchymal stem cells
(MSCs) for cardiac regeneration is dependent on cell–cell
or cell–matrix adhesion, which is inhibited by reactive ox-
ygen species (ROS) generated in ischemic surroundings af-
ter myocardial infarction. Intracellular ROS play a key
role in the regulation of cell adhesion, migration, and pro-
liferation. This study was designed to investigate the role
of ROS on MSC adhesion. In H2O2 treated MSCs, adhe-
sion and spreading were inhibited and detachment was
increased in a dose-dependent manner, and these effects
were significantly rescued by co-treatment with the free
radical scavenger, N-acetyl-L-cysteine (NAC, 1 mM). A
similar pattern was observed on plates coated with differ-
ent matrices such as fibronectin and cardiogel. Hydrogen
peroxide treatment resulted in a marked decrease in the
level of focal adhesion-related molecules, such as phospho-
FAK and p-Src in MSCs. We also observed a significant
decrease in the integrin-related adhesion molecules, aV
and b1, in H2O2 treated MSCs. When injected into
infarcted hearts, the adhesion of MSCs co-injected with
NAC to the border region was significantly improved.
Consequently, we observed that fibrosis and infarct size
were reduced in MSC and NAC-injected rat hearts com-
pared to in MSC-only injected hearts. These results indi-
cate that ROS inhibit cellular adhesion of engrafted MSCs
and provide evidence that the elimination of ROS might
be a novel strategy for improving the survival of engrafted
MSCs. STEM CELLS 2010;28:555–563
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INTRODUCTION
Despite significant advances in the medical management of
heart failure, ischemia/reperfusion injury is still a leading
cause of death in developed countries [1]. In the last few
years, many investigators have shown that mesenchymal
stem cell (MSC) transplantation is a promising tool for the
repair and regeneration of cardiomyocytes and for the resto-
ration of heart function [2–4]. However, the poor survival of
engrafted MSCs is a major obstacle in MSC-based therapy.
In fact, several approaches have been developed to enhance
grafted cell survival. For example, pretreatment with growth
factors, including FGF-2, insulin-like growth factor IGF-1,
and BMP-2, has been shown to improve the efficacy of MSC
implantation [5]. Also, preconditioning MSCs with hypoxia
has been shown to activate the Akt signaling pathway so that
cell viability and cell cycle rates are maintained [6]. Geneti-
cally modified MSCs that overexpress anti-death signals such
as Akt and Bcl-2 also have been shown to be more resistant
to apoptosis in vitro and in vivo. The use of these genetically
modified MSCs has resulted in dramatic improvement in car-
diac function in a rodent myocardial infarction (MI) model,
with almost complete replacement of the infarct scar with
functioning myocardium [6, 7]. Although prosurvival strat-
egies have proven to be successful in several studies, they do
not solve the problems of poor adhesion of MSCs to the cel-
lular matrix. A potentially large contributor to graft cell
death in cell-based cardiac repair is anoikis, which is a pro-
grammed cell death induced by the loss of matrix attach-
ments [8]. Therefore, enhancement of cell adhesion and
spreading should be a major aim in the development of cell
transplantation techniques, including the therapeutic use of
MSCs.
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Once MSCs are injected into the infarcted region, they
initially encounter harsh conditions coupled with the loss of
survival signals because of inadequate interactions between
the cells and the matrix [9]. Reactive oxygen species (ROS)
may intensify anoikis signals in transplanted MSCs at the
infarcted area. In fact, it has been reported that the generation
of ROS is dramatically increased over three-fold in the risk
region in ischemia/reperfusion-injured animal hearts compared
to wild-type animal hearts [10, 11] even though ROS are
formed as a natural component of oxygen respiration [12].
Moreover, recent evidence suggests that disruption of integrin
contacts in fibroblasts can lead to cell detachment that is pre-
ceded by a rise in intracellular ROS levels [13]. Reactive oxy-
gen species can also induce an inflammatory response as well
as hinder cell adhesion, leading to cell death [14]. However,
the role of ROS in implanted stem cell adhesion in infarcted
hearts has not been studied.
In this study, we showed that ROS hinder MSC adhesion
to various kinds of matrices and that the elimination of ROS
in the transplanted region of an infarcted heart can enhance
the adhesiveness of MSCs, leading to greater beneficial
effects in cardiac repair.
MATERIALS AND METHODS
Reagents
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum
(FBS), and penicillin–streptomycin were obtained from Gibco BRL
(Grand Island, NY, http://www.invitrogen.com). Focal adhesion ki-
nases (FAK) and phospho-FAK antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, http://www.scbt.com).
Vinculin, paxillin, Rac1, and p-Src antibodies were from Chemicon
(Chemicon International Inc., Temecula, CA, http://www.chemicon.
com). Horseradish peroxidase-conjugated secondary antibodies to
mouse or rabbit were obtained from Santa Cruz Biotechnology.
The Western blotting detection system was from Amersham Bio-
sciences (Amersham Pharmacia Biotech, Tokyo, Japan, http://
www1.gelifesciences.com). For polymerase chain reaction (PCR),
the oligonucleotides synthesized from Bioneer (Bioneer Corporation,
Daejeon, Korea, http://www.bioneer.co.kr) and RT-&GO were used
for reverse transcription and cDNA synthesis (MP Biomedicals,
Solon, OH, http://www.mpbio.com). N-acetyl-L-cysteine (NAC) was
purchased from Sigma (Sigma, St. Louis, MO, http://www.
sigma.com).
Isolation and Culture of MSCs
Mesenchymal stem cells were purified as previously described [2].
Briefly, bone marrow from femoral and tibial bones of four-week-
old male Sprague-Dawley rats (approximately 100 g) was aspirated
with 10 ml of Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% fetal bovine serum and 1% antibiotic-penicil-
lin/streptomycin solution. Mononuclear cells recovered after cen-
trifugation in Percoll were washed twice, resuspended in 10%
FBS–DMEM, and plated in flasks at 1  106 cells per 100 cm2.
Cultures were maintained at 37C in a humidified atmosphere con-
taining 5% CO2. After 48 or 72 hours, nonadherent cells were dis-
carded, and adherent cells were thoroughly washed twice with
phosphate-buffered saline (PBS). Fresh complete medium was
added and replaced every 3-4 days for approximately 10 days. For
further purification, the Isolex Magnetic Cell Selection System
(Baxter Healthcare Corporation, Irvine, CA, http://www.baxter.
com) was used. Briefly, cells were incubated with Dynabeads M-
450 coated with anti-CD34 monoclonal antibody. A magnetic field
was applied, and CD34þ cell-bead complexes were separated from
the remaining cell suspension; the CD34 fraction was then cul-
tured. Cells were harvested after incubation with 0.25% trypsin
and 1 mM EDTA for 5 minutes at 37C, replated in 1  105 per
100 cm2 plates, and grown for approximately 10 days. The charac-
teristics of MSCs were demonstrated by immunophenotyping. To
verify the nature of cultured MSCs, cells were labeled against vari-
ous surface and intracellular markers and analyzed by flow cytom-
etry. Cells were harvested, washed with PBS, and labeled with the
following antibodies conjugated with fluorescein isothiocyanate
(FITC) or Texas red: CD14, CD34, CD71, CD90, CD105, CD106,
and ICAM-1. FITC-conjugated goat anti-mouse IgG and Texas
red-conjugated goat anti-rabbit IgG from Jackson ImmunoResearch
Laboratories (West Grove, PA, http://www.jacksonimmuno.com)
were used as secondary antibodies. Labeled cells were assayed by
flow cytometry and analyzed with CellQuest Pro Software (Becton-
Dickinson, San Jose, CA, http://www.bd.com).
Assays for Cell Adhesion and Spreading
Suspensions of 2  104 viable MSCs were added to each well of
a four-well plate and allowed to attach for 1 hour at 37C and
5% CO2. Hydrogen peroxide was used as the exogenous ROS
source, and NAC was used as an ROS scavenger. To determine
MSC adhesion, plates were carefully washed three times with
PBS, and then four separate fields were photographed with a
phase-contrast microscope and counted. Each experiment was
performed in triplicate wells and repeated at least three times.
For spreading assays, MSCs were plated for 4 hours on four-well
plates using the conditions of the adhesion experiments described
above. To determine MSC spreading, plates were washed three
times with PBS, fixed with 3% formaldehyde, stained with Coo-
massie blue, and destained, and then four separate fields were
photographed using a phase-contrast microscope.
Measurement of Intracellular ROS
Intracellular ROS were measured using a fluorescent dye tech-
nique. Cells cultured on glass cover slips were treated for 10
minutes with 10 lM 20,70-dichlorofluorescin diacetate
(H2DCFDA; Molecular Probes Inc., Eugene, OR, http://probes.
invitrogen.com) in PBS. The probe H2DCFDA (10 lM) entered
into the cells, and the acetate groups on the H2DCFDAs were
cleaved by cellular esterases, trapping the nonfluorescent 20,70-
dichlorofluorescin (DCFH) within the cells. Subsequent oxida-
tion by reactive oxygen species yielded the fluorescent product
DCF. The coverslips were placed in the chamber, which was
mounted on the stage of an inverted microscope (Axiovert; Carl
Zeiss, Germany, http://www.zeiss.com) equipped with a confocal
laser-scanning system (Oz; Noran Instruments, Middleton, WI,
http://www.thermo.com). The dye, when exposed to an excita-
tion wavelength of 480 nm, emitted light at 535 nm only when
it had been oxidized. Labeled cells were examined for the oxi-
dized dye using a luminescence spectrophotometer. Fluorescence
images were collected using a confocal microscope (Leica,
Solms, Germany, http://www.leica.com) by excitation at 488 nm
and emission greater than 500 nm with a long-pass barrier
filter.
Reverse Transcription PCR Analysis
The expression levels of the various genes were analyzed by
reverse transcription polymerase chain reaction (RT-PCR). Total
RNA was prepared using the Ultraspect-II RNA system (Biotecx
Laboratories Inc., Houston, TX, http://www.biotecx.com), and
single-stranded cDNA was then synthesized from the isolated
total RNA by Avian Myeloblastosis virus (AMV) reverse tran-
scriptase. A 20 ll reverse transcription reaction mixture contain-
ing 1 lg of total RNA, 1 reverse transcription buffer (10 mM
Tris-HCl, pH 9.0, 50 mM KCl, 0.1% Triton X-100), 1 mM deoxynu-
cleoside triphosphates, 0.5 unit of RNase inhibitor, 50 pmol of
oligo(dT)15, and 15 units of AMV reverse transcriptase was incu-
bated at 42C for 15 minutes, heated to 99C for 5 minutes,
and then incubated at 4C for 5 minutes. Polymerase chain reaction
was performed for 35 cycles with 30 and 50 primers based on
the sequences of the various genes. Glyceraldehyde 3-phosphate
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dehydrogenase (GAPDH) (50-CTCCCAACGTGTCTGTTGTG-30
and 50- TGAGCTTGACAAAGTGGTCG-30) was used as an internal
standard. The signal intensity of the amplification product was nor-
malized to its respective GAPDH signal intensity.
Immunoblot Analysis
Cells were washed once in PBS and lysed in buffer (Cell Signaling
Technology, Beverly, MA, http://www.cellsignal.com) containing
20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM Na2-EDTA, 1 mM
EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycer-
ophosphate, 1 mM Na3VO4, 1 mg/ml of leupeptin, and 1 mM phen-
ylmethylsulfonyl fluoride. Protein concentrations were determined
using the Bradford Protein Assay Kit (Bio-Rad, Hercules, CA,
http://www.bio-rad.com). Proteins were separated in a 12% sodium
dodecyl sulfate–polyacrylamide gel and transferred to a polyvinyli-
dene difluoride membrane (Chemicon International Inc.). After
membrane blocking with Tris-buffered saline–Tween 20 (TBS-T,
0.1% Tween 20) containing 5% nonfat dried milk for 1 hour at
room temperature, the membrane was washed twice with TBS-T
and incubated with primary antibody for 1 hour at room temperature
or overnight at 4C. The membrane was washed three times with
TBS-T for 10 minutes and incubated for 1 hour at room temperature
with horseradish peroxidase-conjugated secondary antibodies. After
extensive washing, bands were detected by enhanced chemilumines-
cence reagent (Santa Cruz Biotechnology). Band intensities were
quantified using the Photo-Image System (GE life sciences).
Immunocytochemistry
Cells were grown on four-well plastic dishes, washed twice with
PBS, and then fixed with 4% paraformaldehyde in 0.5 ml of PBS
for 30 minutes at room temperature. The cells were washed again
with PBS and then permeabilized for 30 minutes in PBS contain-
ing 0.2% Triton. Next, the cells were blocked in PBS containing
10% goat serum and incubated for 1 hour with primary antibodies
including aV, Fn, p-FAK, p-Src, Rac1, paxillin, and vinculin. The
cells were washed again three times for 10 minutes with PBS and
incubated with Fluorescein isothiocyanate (FITC)-conjugated goat
anti-rabbit IgG and Texas red-conjugated goat anti-mouse IgG
(Jackson ImmunoResearch, West Grove, PA, http://www.jackso-
nimmuno.com) as secondary antibodies for 1 hour. All images
were produced using an excitation filter under reflected light fluo-
rescence microscopy and transferred to a computer equipped with
MetaMorph software ver. 4.6 (Universal Imaging Corp., Marlow,
U.K., http://www.universal-imaging.co.uk).
Induction of Myocardial Infarction
Experiments were conducted in accordance with the International
Guide for the Care and Use of Laboratory Animals. The protocol
was approved by the Animal Research Committee of the Yonsei
University College of Medicine. Under general anesthesia, eight-
week-old Sprague-Dawley male rats (about 250 g) were intubated,
and positive-pressure ventilation (180 ml/minute) was maintained
with room air supplemented with oxygen (2 l/minute) using a Har-
vard ventilator. The heart was exposed through a 2-cm left lateral
thoracotomy. The pericardium was incised and a 6-0 silk suture
(Johnson & Johnson, Belgium, http://www.jnj.com) was placed
around the proximal portion of the left coronary artery, beneath the
left atrial appendage. Ligature ends were passed through a small
length of plastic tube to form a snare. For coronary artery occlu-
sion, the snare was pressed onto the surface of the heart directly
above the coronary artery, and a hemostat was applied to the snare.
Ischemia was confirmed by the blanching of the myocardium and
dyskinesis of the ischemic region. After 60 minutes of occlusion,
the hemostat was removed and the snare was released for reperfu-
sion, with the ligature left loose on the surface of the heart. Resto-
ration of normal rubor indicated successful reperfusion. Wounds
were sutured, and the thorax was closed under negative pressure.
Rats were weaned from mechanical ventilation and returned to
cages to recover. In sham-operated rats, the same procedure was
executed without tightening the snare.
MSC Labeling and Transplantation
Mesenchymal stem cells were labeled with 40,6-diamidino-2-phe-
nylindole (DAPI) to determine cell viability by adding sterile
DAPI solution to the culture medium for 10 minutes on the day
of implantation, at a final concentration of 50 lg/ml. Cells were
rinsed six times in PBS to remove unbound DAPI. Labeled cells
were trypsinized and suspended in serum-free medium for graft-
ing. For instant transplantation after surgical occlusion of the left
anterior descending coronary artery, MSCs (2  105 cells) were
suspended in 10 ll of serum-free medium with or without NAC
(1 mM final concentration) and kept on ice until injection with a
30-gauge needle on a Hamilton syringe at three sites, into the an-
terior and lateral aspects of the viable myocardium bordering the
infarction. There were four groups of eight rats each used in this
study: (1) normal, (2) NAC control, (3) MSCs control, and (4)
NAC and MSCs-implanted.
Histology and Determination of Myocardial Infarct
Size and Surviving Cells
Transplanted animals were euthanized at three days after implan-
tation and their hearts were excised, perfusion-fixed with 10% (v/
v) neutral-buffered formaldehyde for 24 hours, transversely sec-
tioned into four comparable sections, and embedded in paraffin
using routine methods. The 2-lm sections were mounted onto
gelatin-coated glass slides to allow for the use of different stains
on successive sections of tissue cut through the implantation area.
After deparaffinization and rehydration, the sections were stained
with hematoxylin and eosin to assess nuclei, cytoplasm, and con-
nective tissue. Histological analyses were performed using the
manufacturer’s instructions (Vector Laboratories, Burlingame,
CA, http://www.vectorlabs.com). 2,3,5-Triphenyltetrazolium chlo-
ride (TTC) staining was used to assess myocardial tissue viability
and to determine the size of the myocardial infarct. The tissue sli-
ces were incubated in a 1% TTC (Sigma) solution, pH 7.4, at
37C for 20 minutes. The tissues were fixed in 10% PBS buffered
formalin overnight at 2-8C. The hearts were sectioned transax-
ially, and the size of myocardial infarction was evaluated as a
percentage of the sectional area of the infarcted tissue of the left
ventricle to the sectional area of the whole left ventricle. Both
sides of each TTC-stained tissue slice were photographed with a
digital camera. To evaluate the number of surviving cells, we
photographed four separate fields by fluorescent microscope and
then counted the DAPI-labeled cells. All histological data in this
study was treated and analyzed by three persons blinded.
Terminal Deoxynucleotidyl Transferase-Mediated
dUTP Nick-End Labeling Assay
The transferase-mediated dUTP nick-end labeling (TUNEL) assay
was performed according to the manufacturer’s instructions
(Chemicon International Inc.). In brief, excised heart tissues were
fixed in 3.7% buffered formaldehyde and embedded in paraffin.
Five-micrometer-thick tissue sections were deparaffinized, rehy-
drated, and rinsed with PBS. A positive control sample was pre-
pared from normal heart treated with DNase I (10 U/ml, 10
minutes at room temperature). Sections were pretreated with
3.0% H2O2, subjected to TdT enzyme reaction at 37
C for 1
hour, and incubated with digoxigenin-conjugated nucleotide sub-
strate at 37C for 30 minutes. Nuclei exhibiting DNA fragmenta-
tion were stained with 3,3-diaminobenzidine (DAB) (Vector Lab-
oratories) for 5 minutes. Apoptotic cardiomyocytes nuclei were
stained dark brown. Lastly, sections were counterstained with
methyl green and covered with coverslips. Sections were
observed by light microscopy; six slices per group were prepared,
with ten regions observed on each slice (400).
Determination of Microvessel Density
Histological analyses were performed according to the manufac-
turer’s instructions (R.T.U VECTASTAIN Universal Quick Kit;
Vector Laboratories). In brief, the excised heart tissues were fixed
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in 3.7% buffered formaldehyde and embedded in paraffin. Tissue
sections, 5-lm thick, were deparaffinized, rehydrated, and rinsed
with PBS. Antigen retrieval was performed with 10 mM sodium
citrate (pH 6.0) in a microwave for 10 minutes. Sections were
incubated in 3% H2O2 to quench the endogenous peroxidase. The
samples were blocked in 2.5% normal horse serum and incubated
with anti-CD31 antibodies. Biotinylated pan-specific universal
secondary antibody 1,360 ILK and streptavidin/peroxidase com-
plex reagent were used to treat the heart sections. Using the DAB
substrate kit, the heart sections were stained with antibodies.
Counterstaining was performed with 1% methyl green and dehy-
dration was conducted with 100% N-butanol, ethanol, and xylene
before mounting in VectaMount Mounting Medium (Vector Lab-
oratories). For quantification, capillaries were counted in ten ran-
domly chosen fields from two separate slides at 20. The mean
number of capillaries per field in the infarcted myocardium was
used for statistical analysis.
Statistical Analysis
All quantified data represent an average of at least triplicate sam-
ples. The error bars represent the standard deviation of the mean.
Statistical significance was determined by Student’s t-test, with
p < .05 considered significant.
RESULTS
Scavenging ROS by NAC Rescues the Impaired
MSC Adhesion and Spreading Induced by
Exogenous H2O2
MSCs were isolated from mixed culture with hematopoietic
cells based on their attachment to the culture plate and further
purified by exclusion with magnetic beads targeting the hema-
topoietic marker CD34. Yield was 3  106 cells (95% pu-
rity) after 2 weeks of culture. Consistent with a previous
report [15, 16], the cultured MSCs expressed CD71, CD90,
CD105, CD106, and ICAM-1, but not the hematopoietic and
macrophage markers, CD34 and CD14, respectively (data
not shown).
To determine whether ROS inhibit MSC adhesion, we per-
formed quantitative adhesion assays with MSCs treated exoge-
nously with H2O2. As seen in Figure 1A, the inhibition of MSC
adhesion on cultured plastic surfaces was triggered at an H2O2
concentration of 20 lM and gradually increased in a dose-de-
pendent manner. We observed that the survival and prolifera-
tive activity of MSCs were inhibited starting at a H2O2 concen-
tration of 50 lM (supporting information Fig. 1A), indicating
that 20 lM H2O2 is a sufficiently sublethal level in terms of
inducing the loss of cell–matrix adhesion of MSC.
To confirm that the effects of exogenous H2O2 on the
decrease in MSCs adhesion were specifically due to ROS, we
investigated the effects of the ROS scavenger, NAC, on the
adhesion of H2O2-treated MSCs. First, we confirmed the ROS
scavenging effects of NAC using fluorescence to measure in-
tracellular ROS. We observed that the level of intracellular
ROS markedly increased by two-fold after treatment with
20 lM H2O2, and this increase in ROS was inhibited by treat-
ment with 1 mM NAC (Fig. 1B). We conducted studies using
different concentrations of NAC to examine potential cell ap-
optosis. We observed that 1 mM NAC did not induce any
damage or apoptosis to the cells (data not shown). Therefore,
1 mM NAC was chosen to conduct the following experi-
ments. The H2O2-induced reduction in MSC adhesion was
significantly restored by NAC treatment (Fig. 1C). These
results indicate that ROS inhibits MSC adhesion to the ma-
trix, and this decrease in MSC adhesiveness can be recovered
by the elimination of ROS.
Figure 1. The anti-oxidant, NAC, restores
reactive oxygen species (ROS)-induced
impairment of mesenchymal stem cell
(MSC) adhesion and spreading. (A): The
effects of exogenous ROS and H2O2 on
MSC adhesion. Adhesive differences of
MSCs in the presence of various concentra-
tions of H2O2 were evaluated 1 hour after
plating. (B): Scavenging intracellular ROS
by anti-oxidant, NAC. MSCs were treated
with H2O2 with or without NAC and then
intracellular ROS were measured using
H2DCFDA reagent as described in the
Materials and Methods section. Cell images
were obtained with a confocal laser micro-
scope. (C): The effects of scavenging ROS
and NAC on MSC adhesion in the presence
of H2O2. (D): The effects of exogenous
ROS and H2O2 on MSC spreading with and
without NAC. Values are the average of
three measurements with the S.D. indicated
by error bars (*, p < .05, **, p < .01).
Abbreviations: NAC, N-acetyl-L-cysteine.
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To further confirm the effects of ROS on MSC adhesion
and survival, we performed spreading and trypsinization
assays with H2O2-treated MSCs. Because spreading is
required for the survival of attached cells [17], the absence of
spreading will result in cell death. The spreading of cells was
drastically decreased in H2O2-treated MSC cultures compared
to control MSC cultures at the indicated time (typically
12.5% of control values). We observed that this decrease in
spreading after H2O2 treatment was reversed by NAC pre-
treatment up to the control level (Fig. 1D). We further exam-
ined the adhesion of MSCs on different matrices, such as Fn
and cardiogel, as Fn is well known to act as a receptor for
integrin-related cell adhesion [18]. Furthermore, cardiogel, a
three-dimensional matrix derived from cardiac fibroblasts, has
more biological activities relevant to living organisms in com-
parison to those with 2D matrices. These distinctive in vivo
3D matrix adhesions differ in structure, localization, and func-
tion from classically described in vitro adhesions [19].
Although the cell adhesions to both the Fn-coated plates and
the cardiogel were significantly increased as compared with
adhesion to bare plates, H2O2 treatment significantly reduced
the amount of adhered MSCs at the indicated times, regard-
less of the coating material (supporting information Fig. 1B).
As expected, NAC treatment successfully restored MSC adhe-
sion to the control level. We also observed a similar pattern
in a trypsinization assay, where more cells were easily
detached by 0.025% trypsin from H2O2-treated MSCs cultures
than from control cultures, and the detachment was prevented
by NAC, as shown in supporting information Figure 1C.
ROS Downregulates Adhesion-Related Molecules
in MSCs
Since it is well established that cell adhesion is mediated
mainly by integrin aVb3 and the b1 family integrin a5b1
[20], we evaluated the altered expressions of adhesion-related
integrin molecules in H2O2-treated MSCs using RT-PCR. As
shown in Figure 2A, the mRNA level of b1 was dramatically
decreased by 90% in H2O2-treated MSCs compared to in
control MSCs. Although this decrease was significantly res-
cued by NAC, the level was still 60% that of the control
MSCs. In the case of aV, the mRNA level was also signifi-
cantly decreased by 60% in H2O2-treated MSCs compared
to control MSCs, and the reduced mRNA levels were also
partially rescued by NAC treatment (Fig. 2B). These results
indicate that integrin molecules might partly contribute to the
ROS-induced loss of MSC adhesion, to which other molecules
or mechanisms may be associated.
Integrin is known to activate the cellular focal adhesion-
related kinases FAK and Src at the adhesive stage [21]. In
addition, activated integrins bind to the extracellular matrix to
initiate focal adhesions by recruiting cytoplasmic proteins,
such as FAK, Src, and paxillin, which act as linkers between
integrins and the actin cytoskeleton [22]. Therefore, we inves-
tigated the effects of the above-mentioned proteins at the
early adhesive stage. Hydrogen peroxide treatment signifi-
cantly decreased the phosphorylation of both kinases, FAK
and Src, by 70% compared to that for the control MSCs,
which were rescued by NAC treatment. The rescued phospho-
rylation levels returned to 70% and 90% of initial, respec-
tively, in p-FAK and p-Src of control MSCs (Fig. 2C and
2D). Interestingly, there was a slight, but significant, decrease
in the expression levels of vinculin and paxillin, which were
rescued by NAC treatment (supporting information Fig. 2A
and 2B). We also observed that the level of Rac-1, a small
GTPase that is required for cell adhesion and spreading [23],
was significantly decreased in H2O2-treated MSCs compared
to control MSCs (Fig. 2E). These results indicate that ROS
hinders MSC adhesion through downregulating integrin-de-
pendent adhesion molecules.
ROS Impairs the Distribution and Localization of
Focal Adhesion Proteins in MSCs
Since FAK and Src-dependent integrin signaling events cul-
minate in reorganization of the actin cytoskeleton, which is a
prerequisite for changes in cell shape, adhesion, and gene
expression, we investigated the distribution and localization
of focal adhesion proteins in H2O2-treated MSCs. We first
observed that the cells treated with H2O2 were round and bril-
liant and did not show any cytoskeletal organization, whereas
the control and H2O2-treated cells in the presence of NAC
displayed a tightly adhesive and widened morphology with
membrane ruffles, which began to extend filopodia around 3
hours after adhesion (Fig. 3). Furthermore, double-immuno-
staining showed that integrin b1 and p-FAK were colocalized
Figure 2. Reactive oxygen species downregulates integrin-related
focal adhesion proteins. The mRNA levels of integrin molecules (A)
integrin b1 and (B) integrin aV in H2O2-treated mesenchymal stem
cells with/without NAC were analyzed by reverse transcription poly-
merase chain reaction, and the expression levels of focal adhesion-
related kinases such as (C) p-FAK, (D) Src kinase, and (E) Rac-1 were
analyzed by Western blot. Cells were incubated for 2 hours under des-
ignated conditions and then analyzed. Densitometric analysis of three
independent triplicate Western blots. Values are the average of three
measurements with the S.D. indicated by error bars (*, p < .05, **,
p < .01). Abbreviations: FAK, focal adhesion kinases; GAPDH, glycer-
aldehyde 3-phosphate dehydrogenase; NAC, N-acetyl-L-cysteine.
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at the site of filopodia growth in both the control and H2O2-
treated MSCs in the presence of NAC. This colocalization
suggests that integrin molecules are involved in focal adhesion
formation and cytoskeletal organization in MSCs (Fig. 3A). In
addition, we did not observe any specific staining for focal ad-
hesion proteins such as paxillin, vinculin, or talin in the H2O2-
treated MSCs, whereas both the control and H2O2-treated cells
in the presence of NAC produced numerous peripherally
Figure 3. Reactive oxygen species disrupt the localization of integrin-related focal adhesion proteins. (A): Double immunostaining for integrin b1
and p-FAK. (B): Immunostaining for focal adhesion proteins such a, paxillin, vinculin, and talin. Cells were incubated for 2 hours under the designated
conditions and then immunofluor-stained. Representative images are shown. Abbreviations: FAK, focal adhesion kinases; NAC, N-acetyl-L-cysteine.
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distributed proteins at the site of the prominent membrane ruf-
fles (Fig. 3B). Our results clearly indicate that ROS impairs
MSC adhesion through the disruption of integrin-related focal
adhesion, which can be rescued by treatment with antioxidants
such as NAC.
Scavenging ROS Enhances the Adhesion of
Engrafted MSCs and Improves Myocardial Repair
To investigate whether scavenging ROS facilitated the adhe-
sion of implanted MSCs, we transplanted MSCs labeled with
DAPI with/without NAC into the border region between the
infarcted and normal areas of the heart after coronary ligation.
After three days, the hearts were removed and the fate of the
MSCs was investigated using confocal microscopy. A higher
number of MSCs coupled with NAC were retained in the bor-
der region than in the control MSCs (MSCs-NAC vs. MSCs:
722 6 55 vs. 263 6 48, respectively, p < .001) (Fig. 4A). In
addition, time course experiments indicated enhanced survival
of MSCs in the presence of NAC compared to MSCs in the
absence of NAC (data not shown). One week after coronary
ligation, the size of the left ventricular infarct was evaluated
in both the transplanted and control groups using TTC stain-
ing. The infarct size was significantly lower in the MSC
coupled with NAC-transplanted group than in the naı¨ve MSC-
transplanted group (MSCs vs. MSCs–NAC: 15.8 6 1.03 vs.
6.0 6 0.88, respectively, p < .05) (Fig. 4B). The incidence of
TUNEL-positive myocardial cells was significantly reduced in
the MSC coupled with NAC-transplanted group compared to
the MSC-only-transplanted group (MSCs vs. MSCs–NAC:
14.6 6 1.2% vs. 8.4 6 0.7%, respectively, p < .01) (Fig. 4C).
The mean microvessel count per field in the infarcted myocar-
dium was significantly higher in the MSC coupled with NAC-
transplanted group than in the other group (MSCs vs. MSCs–
NAC: 83 6 14 vs. 127 6 9, respectively, p < .01) (Fig. 4D).
In addition, we observed that treatment of NAC had no
effects on the infarct size, the number of apoptotic cells, and
the microvessel density in our experimental conditions, indi-
cating that the observed beneficial effects were due to
enhanced survival and engraftment of MSCs by elimination
of free radicals in transplanted environment, not directly by
NAC (Fig. 4B–4D).
DISCUSSION
Autologous MSCs offer a great advantage when used to gen-
erate functional cardiac myocytes because they can be easily
prepared from adult patients and they are immunologically
safe. However, the frequency of MSC engraftment is
extremely low despite the implantation of large numbers of
cells due to a low rate of cell adhesion and survival [24]. De-
spite the numerous approaches that have been attempted to
overcome these limitations and dramatically improve cardiac
function in a rodent MI model, there is still no solution to the
Figure 4. Changes in representative histological sections after implantation of MSCs coupled with NAC. (A): Detection of viable MSCs in
ligated hearts by co-injection with NAC. Three days after implantation of DAPI-labeled MSCs into a myocardial infarction (MI)-induced animal,
DAPI-labeled cells were observed by fluorescence microscopy. (B): Intramyocardial co-injection of MSCs with NAC reduced the left ventricular
infarct size as assessed by 2,3,5-triphenyltetrazolium chloride staining at seven days post-MI. (C): Apoptosis assay on heart tissue, one week after
left anterior descending (LAD) ligation. The left panel shows representative transferase-mediated dUTP nick-end labeling staining images (magni-
fication: 200). Staining for normal nuclei (green) was conducted using methyl green, and apoptotic nuclei are brown. (D): Quantitative analysis
for evaluating microvessel density was conducted. Values are the average of three measurements with the S.D. indicated by error bars (*, p <
.05, **, p < .01). Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; MSCs, mesenchymal stem cells; NAC, N-acetyl-L-cysteine.
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problem of anoikis, programmed cell death induced by loss of
matrix attachments [8]. Indeed, engrafted MSCs first encoun-
ter harsh conditions coupled with the loss of survival signals
because of an inadequate interaction between cells and matrix
[9]. Because substantial amounts of ROS are generated in the
high-risk area in ischemia/reperfusion-injured hearts and
because ROS is known to affect cell adhesion, we investi-
gated the effects of ROS on adhesion, spreading, and cellular
signaling of MSCs.
On the basis of our observations, exogenous ROS signifi-
cantly impaired adhesion and spreading of MSCs. However,
scavenging ROS from NAC treatment successfully restored
the altered adhesion and spreading of MSCs, indicating that
hindered adhesion and spreading of MSCs are ROS-specific.
In addition, we observed that the expression levels of integrin
molecules, such as aV and b1, and the phosphorylation of
focal adhesion kinases, such as FAK and Src, were signifi-
cantly decreased in exogenous ROS-treated MSCs but were
rescued by NAC, suggesting that ROS-mediated loss of cell–
matrix adhesion is associated with an integrin-dependent path-
way. In fact, integrins are essential for cell migration and
invasion because they mediate the adhesion of cells to the
extracellular matrix and regulate intracellular signaling path-
ways that control cytoskeletal organization, force generation,
and survival [25]. Focal adhesions are integrin-based struc-
tures that mediate strong cell–substrate adhesion and transmit
information in a bidirectional manner between extracellular
molecules and the cytoplasm [26–28]. Activated integrins
bind to the extracellular matrix, cluster at the binding site,
and initiate focal adhesions by recruiting cytoplasmic pro-
teins, such as focal adhesion kinase (FAK), Src, and paxillin
[21]. Our finding that the expression level of Rac-1 was sig-
nificantly decreased in exogenous ROS-treated MSCs is con-
sistent with the report that integrins activate Rac-1, which in
turn activates downstream effector molecules, leading to the
rearrangement of actin stress fibers and activation of cell ad-
hesion and spreading [23]. Furthermore, we observed a simi-
lar pattern in the loss of adhesion in ROS-treated MSCs on
cardiogel, indicating that ROS may hinder the adhesion of
transplanted MSCs in biological circumstances because cardi-
ogel is a 3D matrix that mimics the biological environment of
the region into which the cells are injected. Immunocyto-
chemical staining for integrin molecules further showed that
ROS disrupted colocalization between integrin b1 and p-FAK
in MSCs and downregulated the expressions of integrin b1
and p-FAK. The distribution of focal adhesion-related proteins
such as paxillin, vinculin, and talin were also disrupted, sug-
gesting that ROS generated in an infarcted area might be a
major obstacle to adhesion and survival of engrafted MSCs
for cardiac repair.
According to our in vivo histological findings, three times
more transplanted MSCs–NAC were retained in the border
region than naı¨ve MSCs. In addition, transplantation of
MSCs–NAC resulted in a further decrease in infarct size and
improvement of microvessel density compared to transplanta-
tion with MSCs in the absence of NAC. Since improvement
in cardiac structure is related to a reduction in infarct size and
a higher capillary density, MSCs–NAC may mediate an
increase in microvessel formation that increases blood flow
within the infarcted area and contributes to inhibition of car-
diac remodeling and subsequent improvement in systolic
function. These histological parameters show that scavenging
ROS coupled with MSC transplantation improves the cardiac
regenerative capacity of MSCs.
CONCLUSION
In this report, we demonstrated that ROS, a major cause of
injury after ischemia/reperfusion, may hinder the adhesion
and spreading of MSCs, and scavenging ROS successfully
improves the adhesiveness of engrafted MSCs in the infarcted
heart, leading to beneficial effects for cardiac repair. In addi-
tion, it was revealed that the loss of adhesion of MSCs by
ROS is dependent on the integrin-related focal adhesion path-
way. Our finding that co-injection of MSCs with antioxidant
enhances the viability and integration potential of MSCs may
provide novel therapeutic opportunities for the treatment of
myocardial infarction and end-stage cardiac failure. In future
studies, dissecting the mechanism of action of adhesion-
related molecules might have important implications for the
development of engrafted stem cell therapy for cardiac repair
in ischemic-injured hearts.
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